Fighting Resistant Tuberculosis With Old Compounds: The Carbapenem Paradigm

Clinical Microbiology and Infection - United Kingdom
doi 10.1111/j.1469-0691.2011.03699.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Associations Between Carbapenem Use, Carbapenem-Resistant Pseudomonas Aeruginosa, and Carbapenem-Resistant Acinetobacter Baumannii

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2013English

Fighting Antibiotic-Resistant Klebsiella Pneumoniae With “Sweet” Immune Targets

mBio
VirologyMicrobiology
2018English

Colistin Plus Carbapenem Versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Pneumonia

Infection and Drug Resistance
Infectious DiseasesPharmacology
2019English

Judging the Appropriate Therapy for Carbapenem-Resistant Acinetobacter Infections

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2019English

Multidrug Resistant Tuberculosis

British Medical Journal
Medicine
2015English

IMP-Producing Carbapenem-Resistant Klebsiella Pneumoniae in the United States

Journal of Clinical Microbiology
Microbiology
2011English

Treatment Options for Carbapenem-Resistant and Extensively Drug-Resistant Acinetobacter Baumannii Infections

Drugs
Pharmacology
2014English

Multicenter Study of Outcomes With Ceftazidime-Avibactam in Patients With Carbapenem-Resistant Enterobacteriaceae Infections

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection With Multidrug-Resistant Enterobacteriaceae

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy